Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood|March 4, 2026
How I Treat HLH-Like Toxicities Following Immune Effector Cell TherapyWilliam T Johnson, Kevin O McNerney, Matthew J Frank, et al.
Cytotherapy|March 16, 2020
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cellsMatthew J Frank, Niclas Olsson, Andy Huang, et al.
Cancer Cytopathology|November 15, 2021
Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapyKelly L Mooney, Debra K Czerwinski, Tanaya Shree, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2023
Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment ResistanceSheren Younes, Shuchun Zhao, Sushma Bharadwaj, et al.
The American Journal of Pathology|September 1, 2009
Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stressCynthia E Balatoni, David W Dawson, Jane Suh, et al.
Journal of Neuropathology and Experimental Neurology|January 2, 2023
Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphomaEsther H Nie, Saman S Ahmadian, Sushma N Bharadwaj, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
American Journal of Hematology|May 4, 2026
Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease RelapseSnegha Ananth, Neha Agarwal, Bita Sahaf, et al.
Cancer Discovery|August 30, 2018
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent LymphomaMatthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.
Transplantation and Cellular Therapy|March 29, 2021
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell TransplantationEmily C Liang, Lori S Muffly, Parveen Shiraz, et al.
Pageof 5